507 related articles for article (PubMed ID: 26072064)
1. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Tang SC; Lai KN
Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Guo H; Lai KN
Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
6. PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells.
Huang CD; Hsiung TC; Ho SC; Lee KY; Chan YF; Kuo LW; Lin SM; Wang CH; Lin HC; Kuo HP
Biomed J; 2014; 37(4):191-8. PubMed ID: 25116714
[TBL] [Abstract][Full Text] [Related]
7. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ).
Miana M; de Las Heras N; Rodriguez C; Sanz-Rosa D; Martin-Fernandez B; Mezzano S; Lahera V; Martinez-Gonzalez J; Cachofeiro V
J Physiol Pharmacol; 2011 Feb; 62(1):87-94. PubMed ID: 21451213
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.
Li X; Kimura H; Hirota K; Sugimoto H; Kimura N; Takahashi N; Fujii H; Yoshida H
Nephrol Dial Transplant; 2007 Apr; 22(4):1041-51. PubMed ID: 17255125
[TBL] [Abstract][Full Text] [Related]
11. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model.
Lee S; Kim W; Kang KP; Moon SO; Sung MJ; Kim DH; Kim HJ; Park SK
Nephrol Dial Transplant; 2005 Jun; 20(6):1057-65. PubMed ID: 15797891
[TBL] [Abstract][Full Text] [Related]
12. Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.
Song Y; Zhao H; Liu J; Fang C; Miao R
Inflammation; 2016 Apr; 39(2):663-71. PubMed ID: 26658749
[TBL] [Abstract][Full Text] [Related]
13. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Park SK
Nephrol Dial Transplant; 2006 Aug; 21(8):2096-105. PubMed ID: 16728429
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
17. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
Tang SC; Leung JC; Chan LY; Tsang AW; Lai KN
J Am Soc Nephrol; 2006 Jun; 17(6):1633-43. PubMed ID: 16687627
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferating activating receptor gamma-independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones.
McKinnon B; Bersinger NA; Mueller MD
Fertil Steril; 2012 Mar; 97(3):657-64. PubMed ID: 22192353
[TBL] [Abstract][Full Text] [Related]
20. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
Kimura H; Li X; Torii K; Okada T; Takahashi N; Fujii H; Ishihara S; Yoshida H
Nephrol Dial Transplant; 2008 Aug; 23(8):2496-503. PubMed ID: 18367541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
